IntraLinks Alliance with Quorum Review to Bring New Efficiencies to Investigator Review Process
Partnership is latest step in IntraLinks development of pharmaceutical hub

New York, January 14, 2003
IntraLinks, Inc., the leading provider of secure digital workspaces to the financial services and pharmaceutical markets, today announced that it has entered into a co-marketing agreement with Quorum Review Inc., an Institutional Review Board. A Quorum Review template will now be available within IntraLinks' clinical trial workspaces for potential investigators to utilize when submitting credentials for review.

"We work with hundreds of sponsors, contract research organizations, site management organizations and investigators. By using IntraLinks we are reinforcing our commitment to innovative methods of assistance in the clinical trial process and the reduction of turnaround time," said Greg Fritz, CEO of Quorum Review.

"Our partnership with Quorum Review provides our pharmaceutical clients with yet another link to an integral component of the clinical trial process. The IRB community on IntraLinks has grown tremendously over the past year, and we expect this growth to continue as we bring more IRBs into our drug development hub," said Richard Jenkins, General Manager of Life Sciences at IntraLinks.

IntraLinks' service connects members of the pharmaceutical community and accelerates the flow of information among IRBs, CROs, SMOs, investigators and pharmaceutical companies. By forming alliances with Quorum and other IRBs around the country, IntraLinks brings additional efficiencies to study start up for its pharmaceutical clients.

About Quorum Review
Quorum Review was founded in 1992 and is one of the leading independent IRBs in the United States. The mission of Quorum Review is to safeguard the rights and well-being of research participants while enhancing the clinical research process. The company core values are the protection of human research subjects, customer service, promotion of organizational capability and continuous quality improvement. The five year goal of the company is to become the best IRB in the world as determined by its customers. Quorum Review was most recently audited by the FDA in 2000 and 2002. Both audits resulted in a finding of NAI - no action indicated - the highest possible classification.

About IntraLinks
IntraLinks (www.intralinks.com), the leading provider of digital workspaces, connects business communities and accelerates the intelligent flow of information and documents among participants. Through IntraLinks' secure, neutral, online environments, companies are better able to compete globally by accelerating essential business processes, simplifying communication, and fostering rapid workflow. IntraLinks is easily accessible anywhere, anytime using a web browser.

Since April 1997, more than 100,000 participants representing over 3,000 companies worldwide have used IntraLinks digital workspaces to communicate and collaborate on more than 10,000 projects and transactions. IntraLinks has been rapidly adopted by the financial services and pharmaceutical markets. Over 100 global companies are IntraLinks clients, including AstraZeneca Pharmaceuticals LP; Bank of America; Bank One; Bear Stearns; Deutsche Bank; Dresdner Kleinwort Wasserstein; Ernst & Young; FDIC; Houlihan Lokey Howard & Zukin; International Finance Corporation (World Bank Group); JPMorgan Chase; TD Securities; Thomas Weisel Partners; Wachovia Securities; and WestLB. Founded in June 1996, IntraLinks is headquartered in New York with offices in Boston and London.